Role of IFI16 in Cellular Senescence
Role of IFI16 in Cellular Senescence
批准号:
7613399
负责人:
DIVAKER CHOUBEY
金额:
$24.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2012-04-30
关键词:
1q22AffectBindingBiochemicalBiological AssayCell AgingCell Cycle ArrestCellsDimerizationDiploidyDown-RegulationE2F1 geneEctopic ExpressionEpithelial CellsFibroblastsGene ExpressionGene TargetingGenesGeneticGenetic TranscriptionGrowthHeterochromatinHumanHuman Cell LineHypoxiaIonizing radiationLengthMediatingMolecularOncogenesPathway interactionsPost-Translational Protein ProcessingProtein BindingProtein FamilyProteinsRadiation Induced DNA DamageRegulationRoleSerumStressTERT geneTP53 geneTelomeraseTelomerase inhibitionTestingTranscriptional ActivationUp-Regulationbasec-myc Genescell growthchromatin immunoprecipitationcobaltous chloridedesignexhaustin vivokeratinocytemutantnovelprematurepromoterresearch studysenescencetelomeretranscription factor
中文摘要
细胞衰老是指细胞在耗尽其细胞周期后所显示的不可逆的细胞周期停滞。
复制潜力尽管p53、Rb和端粒的磨损与细胞凋亡的调控有关,
衰老,分子机制,有助于不可逆的细胞周期停滞,其特征在于不同的
基因表达的变化仍有待阐明。这些拟议研究的主要目标是了解
IFI16蛋白(由位于1q22的/F/76基因编码)是一种可诱导的蛋白,
转录调节因子,有助于细胞衰老相关的细胞周期停滞。
我们使用人上皮细胞和人二倍体成纤维细胞(HDFs)的实验揭示了以前的
IFI16在细胞衰老调节中的作用未知。然而,其分子机制仍不清楚。
基于我们的初步和其他观察,我们假设IFI16有助于细胞衰老-
通过与转录因子如p53、Rb-E2F和c-Myc相互作用,以及通过调节细胞周期,
它们的转录活性。以下三个具体目标旨在验证我们的假设:目标#1:为了
确定IFI16和p53之间的相互作用是否有助于p21基因的转录激活,并限制p21基因的表达。
HDFs的增殖潜力。我们建议:(i)确定是否衰老相关的翻译后
IFI16和p53的修饰影响它们的物理相互作用;(ii)确定IFI16
增加p53介导的p21基因的转录激活;和(iii)比较IFI16对细胞生长的抑制
在p53(p53 +/+对p53 +/-)或p21 CIR1(p21 +/+对p21 +/-)表达不同的同基因HDF之间。遗传
和生物化学方法,包括染色质免疫沉淀试验(ChlPs),将被使用。目标2:
确定IFI16与Rb和E2F的相互作用是否增强E2F靶基因的沉默。我们建议
确定:(i)IFI16是否以LxCxE基序依赖性方式与Rb口袋结合,以及口袋突变体是否
(ii)IFI16与E2F家族蛋白的结合抑制了E2F的二聚化
与DP家族蛋白和E2F介导的转录;和(iii)IFI16增强Rb介导的异染色质
E2F靶基因如hTERT的形成和沉默。目标#3:通过以下方法阐明分子机制:
其中IFI16负调控hTERT基因的转录。我们将确定是否:(i)IFI16的敲除
HDFs中的表达增加hTERT表达和端粒酶活性;(ii)IFI16与c-Myc的结合抑制hTERT表达和端粒酶活性。
c-Myc与其配偶体Max的二聚化和c-Myc介导的转录;(iii)c-Myc与其配偶体Max的二聚化和c-Myc介导的转录的增加或减少。
IFI16表达对c-Myc与hTERT启动子结合及c-Myc介导的hTERT转录的影响
基因我们提出的实验的意义在于,它们将确定IFI16
调节衰老相关基因的转录,并促进衰老相关细胞周期
逮捕了
英文摘要
Cellular senescence refers to the irreversible cell cycle arrest displayed by cells that have exhausted their
replicative potential. Although the p53, Rb, and telomere attrition have been implicated in the regulation of cellular
senescence, molecular mechanisms contributing to irreversible cell cycle arrest that is characterized by distinct
changes in gene expression remain to be elucidated. The main objective of these proposed studies is to understand
the molecular mechanisms by which IFI16 protein (encoded by the /F/76gene located at 1q22), an inducible
transcriptional regulator, contributes to cellular senescence-associated cell cycle arrest.
Our experiments using human epithelial cells and human diploid fibroblasts (HDFs) have revealed a previously
unknown role for IFI16 in the regulation of cellular senescence. However, the molecular mechanisms remain unknown.
Based on our preliminary and other observations, we hypothesize that IFI16 contributes to cellular senescence-
associated cell cycle arrest by interacting with transcription factors, such as p53, Rb-E2F, and c-Myc, and by regulating
their transcriptional activities. The following three specific aims are designed to test our hypothesis: Aim #1: To
determine whether interactions between IFI16 and p53 contribute to transcriptional activation of p21 gene and limit the
proliferative potential of HDFs. We propose to: (i) determine whether senescence-associated posttranslational
modifications of IFI16 and p53 affect their physical interactions; (ii)identify the molecular mechanisms by which IFI16
increases p53-mediated transcriptional activation of p21 gene; and (iii)compare inhibition of cell growth by IFI16
between isogenic HDFs differing in the expression of p53 (p53+/+ versus p53"'~) or p21CIR1 (p21+/+ versus p21"A). Genetic
and biochemical approaches, including chromatin immunoprecipitation assays (ChlPs), will be used. Aim# 2: To
determine whether interactions of IFI16 with Rb and E2F potentiate silencing of the E2F target genes. We propose to
determine whether: (i) IFI16 binds to Rb pocket in an LxCxE-motif-dependent manner and whether the pocket mutants
of Rb are defective in binding to IFI16; (ii)binding of IFI16 to the E2F-family of proteins inhibits dimerization of E2Fs
with DP-family of proteins and E2F-mediated transcription; and (iii) IFI16 potentiates the Rb-mediated heterochromatin
formation and silencing of the E2F target genes, such as hTERT. Aim# 3: To elucidate molecular mechanisms by
which IFI16 negatively regulates the transcription of hTERT gene. We will determine whether: (i) knockdown of IFI16
expression in HDFs increases hTERT expression and the telomerase activity; (ii)binding of IFI16 to c-Myc inhibits
dimerization of c-Myc with its partner Max and the c-Myc-mediated transcription; (iii)increases or decreases in the
expression of IFI16 affect binding of c-Myc to hTERT promoter in v/Voand c-Myc-mediated transcription of hTERT
gene. The significance of our proposed experiments is that they will identify molecular mechanisms by which IFI16
regulates the transcription of senescence-associated genes and contributes to the senescence-associated cell cycle
arrest.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0019532
发表时间:
2011-05-05
期刊:
PloS one
影响因子:
3.7
作者:
[Duan X, Ponomareva L, Veeranki S, Choubey D]
通讯作者:
Choubey D
DOI:
10.1371/journal.pone.0008569
发表时间:
2010-01-05
期刊:
PloS one
影响因子:
3.7
作者:
[Song LL, Ponomareva L, Shen H, Duan X, Alimirah F, Choubey D]
通讯作者:
Choubey D
DOI:
10.1158/1541-7786.mcr-10-0565
发表时间:
2011-05
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
[Duan X, Ponomareva L, Veeranki S, Panchanathan R, Dickerson E, Choubey D]
通讯作者:
Choubey D
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8795672
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8481178
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8696826
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
AIM2 and IFI16 Innate Immune Sensors for Cytosolic DNA in Prostatic Diseases
-
批准号:8329212
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of Aim2 in Inflammation and Autoimmunity
-
批准号:8317789
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI16 in Cellular Senescence
-
批准号:7415050
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2006
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI16 in Cellular Senescence
-
批准号:7091879
-
项目类别:
-
资助金额:$24.35万
-
财政年份:2006
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI16 in Cellular Senescence
-
批准号:7438836
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2006
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7192486
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7485797
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7914357
-
项目类别:
-
资助金额:$36.1万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7068073
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:7740619
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Gender-Specific Role of p202 in Lupus Susceptibility
-
批准号:6959452
-
项目类别:
-
资助金额:$25.25万
-
财政年份:2005
-
负责人:DIVAKER CHOUBEY
-
依托单位:
Role of IFI 16 in Cellular Senescence and Aging
-
批准号:6614227
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2003
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2443212
-
项目类别:
-
资助金额:$9.95万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2825892
-
项目类别:
-
资助金额:$11.27万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:6172809
-
项目类别:
-
资助金额:$11.72万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2113102
-
项目类别:
-
资助金额:$9.56万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
INTERFERONS AND CELL GROWTH REGULATION
-
批准号:2733191
-
项目类别:
-
资助金额:$10.83万
-
财政年份:1996
-
负责人:DIVAKER CHOUBEY
-
依托单位:
海外基金